This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Milasincic, D. J.
Right arrow Articles by Pilch, P. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Milasincic, D. J.
Right arrow Articles by Pilch, P. F.

 Previous Article  |  Next Article 

Mol. Cell. Biol., 11 1996, 5964-5973, Vol 16, No. 11
Copyright © 1996, American Society for Microbiology

Stimulation of C2C12 myoblast growth by basic fibroblast growth factor and insulin-like growth factor 1 can occur via mitogen-activated protein kinase-dependent and -independent pathways

DJ Milasincic, MR Calera, SR Farmer and PF Pilch
Department of Biochemistry, Boston University Medical School, Massachusetts 02118, USA.

It is now well-recognized that the mitogen-activated protein (MAP) kinase cascade facilitates signaling from an activated tyrosine kinase receptor to the nucleus. In fact, an increasing number of extracellular effectors have been reported to activate the MAP kinase cascade, with a significant number of cellular responses attributed to this activation. We set out to explore how two extracellular effectors, basic fibroblast growth factor (bFGF) and insulin-like growth factor 1 (IGF-1), which have both been reported to activate MAP kinase, generate quite distinct cellular responses in C2C12 myoblasts. We demonstrate here that bFGF, which is both a potent mitogen and inhibitor of myogenic differentiation, is a strong MAP kinase agonist. By contrast, IGF-1, which is equally mitogenic for C2C12 cells but ultimately enhances the differentiated phenotype, is a weak activator of the MAP kinase cascade. We further demonstrate that IGF-1 is a potent activator of both insulin receptor substrate IRS-1 tyrosyl phosphorylation and association of IRS-1 with activated phosphatidylinositol 3-kinase (PI 3- kinase). Finally, use of the specific MAP kinase kinase inhibitor, PD098059, and wortmannin, a PI 3-kinase inhibitor, suggests the existence of an IGF-1-induced, MAP kinase-independent signaling event which contributes to the mitogenic response of this factor, whereas bFGF-induced mitogenesis appears to strongly correlate with activation of the MAP kinase cascade.


This article has been cited by other articles:

  • Yahiaoui, L., Gvozdic, D., Danialou, G., Mack, M., Petrof, B. J. (2008). CC family chemokines directly regulate myoblast responses to skeletal muscle injury. J. Physiol. 586: 3991-4004 [Abstract] [Full Text]  
  • Odemis, V., Boosmann, K., Dieterlen, M. T., Engele, J. (2007). The chemokine SDF1 controls multiple steps of myogenesis through atypical PKC{zeta}. J. Cell Sci. 120: 4050-4059 [Abstract] [Full Text]  
  • Jones, N. C., Tyner, K. J., Nibarger, L., Stanley, H. M., Cornelison, D. D.W., Fedorov, Y. V., Olwin, B. B. (2005). The p38{alpha}/{beta} MAPK functions as a molecular switch to activate the quiescent satellite cell. JCB 169: 105-116 [Abstract] [Full Text]  
  • Phornphutkul, C., Wu, K.-Y., Yang, X., Chen, Q., Gruppuso, P. A (2004). Insulin-like growth factor-I signaling is modified during chondrocyte differentiation. J Endocrinol 183: 477-486 [Abstract] [Full Text]  
  • Sasson, I. E., Stern, M. J. (2004). FGF and PI3 kinase signaling pathways antagonistically modulate sex muscle differentiation in C. elegans. Development 131: 5381-5392 [Abstract] [Full Text]  
  • Natalicchio, A., Laviola, L., De Tullio, C., Renna, L. A., Montrone, C., Perrini, S., Valenti, G., Procino, G., Svelto, M., Giorgino, F. (2004). Role of the p66Shc Isoform in Insulin-like Growth Factor I Receptor Signaling through MEK/Erk and Regulation of Actin Cytoskeleton in Rat Myoblasts. J. Biol. Chem. 279: 43900-43909 [Abstract] [Full Text]  
  • French, D. M., Kaul, R. J., D'Souza, A. L., Crowley, C. W., Bao, M., Frantz, G. D., Filvaroff, E. H., Desnoyers, L. (2004). WISP-1 Is an Osteoblastic Regulator Expressed During Skeletal Development and Fracture Repair. Am. J. Pathol. 165: 855-867 [Abstract] [Full Text]  
  • Sasaoka, T., Kikuchi, K., Wada, T., Sato, A., Hori, H., Murakami, S., Fukui, K., Ishihara, H., Aota, R., Kimura, I., Kobayashi, M. (2003). Dual Role of Src Homology Domain 2-Containing Inositol Phosphatase 2 in the Regulation of Platelet-Derived Growth Factor and Insulin-Like Growth Factor I Signaling in Rat Vascular Smooth Muscle Cells. Endocrinology 144: 4204-4214 [Abstract] [Full Text]  
  • Prusty, D., Park, B.-H., Davis, K. E., Farmer, S. R. (2002). Activation of MEK/ERK Signaling Promotes Adipogenesis by Enhancing Peroxisome Proliferator-activated Receptor gamma (PPARgamma ) and C/EBPalpha Gene Expression during the Differentiation of 3T3-L1 Preadipocytes. J. Biol. Chem. 277: 46226-46232 [Abstract] [Full Text]  
  • Yoshiko, Y., Hirao, K., Maeda, N. (2002). Differentiation in C2C12 myoblasts depends on the expression of endogenous IGFs and not serum depletion. Am. J. Physiol. Cell Physiol. 283: C1278-C1286 [Abstract] [Full Text]  
  • Kontaridis, M. I., Liu, X., Zhang, L., Bennett, A. M. (2002). Role of SHP-2 in Fibroblast Growth Factor Receptor-Mediated Suppression of Myogenesis in C2C12 Myoblasts. Mol. Cell. Biol. 22: 3875-3891 [Abstract] [Full Text]  
  • Sumitani, S., Goya, K., Testa, J. R., Kouhara, H., Kasayama, S. (2002). Akt1 and Akt2 Differently Regulate Muscle Creatine Kinase and Myogenin Gene Transcription in Insulin-Induced Differentiation of C2C12 Myoblasts. Endocrinology 143: 820-828 [Abstract] [Full Text]  
  • Arsenijevic, Y., Weiss, S., Schneider, B., Aebischer, P. (2001). Insulin-Like Growth Factor-I Is Necessary for Neural Stem Cell Proliferation and Demonstrates Distinct Actions of Epidermal Growth Factor and Fibroblast Growth Factor-2. J. Neurosci. 21: 7194-7202 [Abstract] [Full Text]  
  • Karagiannides, I., Tchkonia, T., Dobson, D. E., Steppan, C. M., Cummins, P., Chan, G., Salvatori, K., Hadzopoulou-Cladaras, M., Kirkland, J. L. (2001). Altered expression of C/EBP family members results in decreased adipogenesis with aging. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280: R1772-R1780 [Abstract] [Full Text]  
  • Pozios, K. C., Ding, J., Degger, B., Upton, Z., Duan, C. (2001). IGFs stimulate zebrafish cell proliferation by activating MAP kinase and PI3-kinase-signaling pathways. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280: R1230-R1239 [Abstract] [Full Text]  
  • Taylor, W. E., Bhasin, S., Artaza, J., Byhower, F., Azam, M., Willard, D. H. Jr., Kull, F. C. Jr., Gonzalez-Cadavid, N. (2001). Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells. Am. J. Physiol. Endocrinol. Metab. 280: E221-E228 [Abstract] [Full Text]  
  • Boney, C. M., Gruppuso, P. A., Faris, R. A., Frackelton, A. R. Jr. (2000). The Critical Role of Shc in Insulin-Like Growth Factor-I-Mediated Mitogenesis and Differentiation in 3T3-L1 Preadipocytes. Mol. Endocrinol. 14: 805-813 [Abstract] [Full Text]  
  • Beer, H.-D., Vindevoghel, L., Gait, M. J., Revest, J.-M., Duan, D. R., Mason, I., Dickson, C., Werner, S. (2000). Fibroblast Growth Factor (FGF) Receptor 1-IIIb Is a Naturally Occurring Functional Receptor for FGFs That Is Preferentially Expressed in the Skin and the Brain. J. Biol. Chem. 275: 16091-16097 [Abstract] [Full Text]  
  • Haugk, K. L., Wilson, H.-M. P., Swisshelm, K., Quinn, L. S. (2000). Insulin-Like Growth Factor (IGF)-Binding Protein-Related Protein-1: An Autocrine/Paracrine Factor That Inhibits Skeletal Myoblast Differentiation but Permits Proliferation in Response to IGF. Endocrinology 141: 100-110 [Abstract] [Full Text]  
  • Skrtic, S., Wallenius, K., Gressner, A. M., Jansson, J.-O. (1999). Insulin-Like Growth Factor Signaling Pathways in Rat Hepatic Stellate Cells: Importance for Deoxyribonucleic Acid Synthesis and Hepatocyte Growth Factor Production. Endocrinology 140: 5729-5735 [Abstract] [Full Text]  
  • Klingenberg, O., Olsnes, S. (1999). Effects of Mutations of a Phosphorylation Site in an Exposed Loop in Acidic Fibroblast Growth Factor. J. Biol. Chem. 274: 18081-18086 [Abstract] [Full Text]  
  • Zheng, J., Bird, I. M., Melsaether, A. N., Magness, R. R. (1999). Activation of the Mitogen-Activated Protein Kinase Cascade Is Necessary But Not Sufficient for Basic Fibroblast Growth Factor- and Epidermal Growth Factor-Stimulated Expression of Endothelial Nitric Oxide Synthase in Ovine Fetoplacental Artery Endothelial Cells. Endocrinology 140: 1399-1407 [Abstract] [Full Text]  
  • Giuliani, R, Bastaki, M, Coltrini, D, Presta, M (1999). Role of endothelial cell extracellular signal-regulated kinase1/2 in urokinase-type plasminogen activator upregulation and in vitro angiogenesis by fibroblast growth factor-2. J. Cell Sci. 112: 2597-2606 [Abstract]  
  • Sarbassov, D. D., Peterson, C. A. (1998). Insulin Receptor Substrate-1 and Phosphatidylinositol 3-Kinase Regulate Extracellular Signal-Regulated Kinase-Dependent and -Independent Signaling Pathways during Myogenic Differentiation. Mol. Endocrinol. 12: 1870-1878 [Abstract] [Full Text]  
  • Fedorov, Y. V., Jones, N. C., Olwin, B. B. (1998). Regulation of Myogenesis by Fibroblast Growth Factors Requires Beta-Gamma Subunits of Pertussis Toxin-Sensitive G Proteins. Mol. Cell. Biol. 18: 5780-5787 [Abstract] [Full Text]  
  • Chauhan-Patel, R, Spruce, A E (1998). Differential regulation of potassium currents by FGF-1 and FGF-2 in embryonic Xenopus laevis myocytes. J. Physiol. 512: 109-118 [Abstract] [Full Text]  
  • Boney, C. M., Smith, R. M., Gruppuso, P. A. (1998). Modulation of Insulin-Like Growth Factor I Mitogenic Signaling in 3T3-L1 Preadipocyte Differentiation. Endocrinology 139: 1638-1644 [Abstract] [Full Text]  
  • Weyman, C. M., Wolfman, A. (1998). Mitogen-Activated Protein Kinase Kinase (MEK) Activity Is Required for Inhibition of Skeletal Muscle Differentiation by Insulin-Like Growth Factor 1 or Fibroblast Growth Factor 2. Endocrinology 139: 1794-1800 [Abstract] [Full Text]  
  • Xie, H, Pallero, M., Gupta, K, Chang, P, Ware, M., Witke, W, Kwiatkowski, D., Lauffenburger, D., Murphy-Ullrich, J., Wells, A (1998). EGF receptor regulation of cell motility: EGF induces disassembly of focal adhesions independently of the motility-associated PLCgamma signaling pathway. J. Cell Sci. 111: 615-624 [Abstract]  
  • Dufourny, B., Alblas, J., van Teeffelen, H. A. A. M., van Schaik, F. M. A, van der Burg, B., Steenbergh, P. H., Sussenbach, J. S. (1997). Mitogenic Signaling of Insulin-like Growth Factor I in MCF-7 Human Breast Cancer Cells Requires Phosphatidylinositol 3-Kinase and Is Independent of Mitogen-activated Protein Kinase. J. Biol. Chem. 272: 31163-31171 [Abstract] [Full Text]  
  • Sarbassov, D. D., Jones, L. G., Peterson, C. A. (1997). Extracellular Signal-Regulated Kinase-1 and -2 Respond Differently to Mitogenic and Differentiative Signaling Pathways in Myoblasts. Mol. Endocrinol. 11: 2038-2047 [Abstract] [Full Text]  
  • Coolican, S. A., Samuel, D. S., Ewton, D. Z., McWade, F. J., Florini, J. R. (1997). The Mitogenic and Myogenic Actions of Insulin-like Growth Factors Utilize Distinct Signaling Pathways. J. Biol. Chem. 272: 6653-6662 [Abstract] [Full Text]  
  • Chakravarthy, M. V., Abraha, T. W., Schwartz, R. J., Fiorotto, M. L., Booth, F. W. (2000). Insulin-like Growth Factor-I Extends in Vitro Replicative Life Span of Skeletal Muscle Satellite Cells by Enhancing G1/S Cell Cycle Progression via the Activation of Phosphatidylinositol 3'-Kinase/Akt Signaling Pathway. J. Biol. Chem. 275: 35942-35952 [Abstract] [Full Text]  
  • Tortorella, L. L., Milasincic, D. J., Pilch, P. F. (2001). Critical Proliferation-independent Window for Basic Fibroblast Growth Factor Repression of Myogenesis via the p42/p44 MAPK Signaling Pathway. J. Biol. Chem. 276: 13709-13717 [Abstract] [Full Text]